DEPENDENCE OF OUTCOMES OF HYPERTROPHIC SCARS LASER TREATMENT ON THE INITIAL REACTIVITY
https://doi.org/10.12737/23736
Abstract
The purpose of the study was to identify the relationship between the initial state of the organism and the result of the treatment of hypertrophic scars. 38 women of 16-35years of age were examined on the 5-7th days of the menstrual cycle, 16 of them had normotrophic scars and 22 - hypertrophic scars. The quality of scars, lipid profile, the concentration of thyrotropin, free fraction of thyroxine, growth hormone (GH), luteinizing and follicle stimulating hormone (FSH), cortisol, prolactin, estradiol, testosterone, progesterone, the concentration of TNF-a, lL-4, lL-6, lL-10, and the level of autoantibodies to DNA, lFN-a, lFN-y, b2-glycoprotein, Fc-fragments, collagen-2 were determined. Further on the laser treatment was performed: the scar surface was treated by multiple perforations under local anesthesia. Treatment outcome was assessed in 3 months by the clinical characteristics of the scar. lt was found that in 10 women hypertrophic scars reformed in normotrophic scars after the treatment, and 12 women still had hypertrophic scars. Patients with a positive result of treatment had a low concentration of GH (0.5 ± 0.1) and high concentrations of progesterone (6.0 ± 0.4) and FSH (6.7 ± 0.5 in the follicular phase of the cycle). The negative result of the treatment obtained in patients with significant shifts reactivity indicators: high atherogenic index (2.6 ± 0.2) and the level of GH (2.1 ± 0.5), low levels of cortisol (346.8 ± 39), testosterone (1.5 ± 0.2), lL-10 (3.89 ± 1.6) and antibodies to lFN-y (0.206 ± 0.05), lFN-a (0.385 ± 0.02), Fc-fragments (0.317± 0.04).
About the Authors
M. V. Kobets
Медицинский центр ЗАО «Эндокринологический центр»
Russian Federation
Russian Federation
L. S. Vasilyeva
ФГБОУ ВО «Иркутский государственный медицинский университет»
Russian Federation
Russian Federation
References
1. Поляков Л.М., Суменкова Д.В., Князев Р.А. Анализ взаимодействия липопротеинов и стероидных гормонов // Биомедицинская химия. - 2011. - Т. 57, Вып. 3. - С. 308-313. Polyakov LM, Sumenkova DV, Knyazev RA (2011). Analysis of the interaction of lipoproteins and steroid hormones [Analiz vzaimodeystviya lipoproteinov i steroidnykh gormonov]. Biomeditsinskaya khimiya, 57 (3), 308-313.
2. Тенчурина Т.Г. Значение половых стероидов и ангиогенных факторов роста в профилактике осложнений рубцевания после косметических операций // Экспериментальная и клиническая дерматокосметология. - 2005. - № 4. - С. 17-20. Tenchurina TG (2005). Significance of sex steroids and angiogenic growth factors in the prevention of scarring complications after cosmetic surgery [Znachenie polovykh steroidov i angiogennykh faktorov rosta v profilaktike oslozhneniy rubtsevaniya posle kosmeticheskikh operatsiy]. Eksperimental'naya i klinicheskaya dermatokosmetologiya, (4), 17-20.
3. Шварц Я.Ш. Действие холестерина и агонистов ядерных гормональных рецепторов на продукцию трансформирующего фактора роста-бета в макрофагах // Бюллетень экспериментальной биологии и медицины. - 2009. - № 9. - С. 294-297. Schwartz YS (2009). Effects of cholesterol and nuclear hormone receptor agonists in the production of transforming growth factor-beta in macrophages [Deystvie kholesterina i agonistov yadernykh gormonal’nykh retseptorov na produktsiyu transformiruyushchego faktora rosta-beta v makrofagakh]. Byulleten' eksperimental'noy biologii i meditsiny, (9), 294-297.
4. Ashcroft GS, Dodsworth J, van Boxtel E (1997). Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med., 3 (11), 1209-1215.
5. Gilliver SC (2006). Androgens modulate the inflammatory response during acute wound healing. J. Cell Sci., 119 (4), 722-732.
6. Fruchtman S, Simmons JG, Michaylira CZ (2005). Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am. J.Physiol. Gastrointest. Liver Physiol., 289 (2), 342-350.
7. Hu ZC, Tang B, Guo D, Zhang J, Liang YY, Ma D, Zhu JY (2014). Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin. Exp. Dermatol, 39 (7), 822-828.
8. Kanda N, Watanabe S (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci., 38 (1), 1-7.
9. Karamouti M, Kollia P, Kallitsaris A, Vamvakopoulos N, Kollios G, Messinis IE (2008) Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil. Steril, 90 (4), 1444-1450.
10. Lawrence JW (2012). Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J. Burn. Care Res., 33 (1), 136-146.
11. Schmidt M, Renner C, Löffler G (1998) Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J. Endocrinol., 158 (3), 401-407.
12. Taketani T, Yamagata Y, Takasaki A, Matsuoka A, Tamura H, Sugino N (2008) Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells. Fertil. Steril., 90 (3), 744-748.
13. Van Vugt HH (2008). Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids. Exp. Brain. Res., 188 (4), 483-491.
14. Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007). Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen., 15 (4), 530-539.
15. Zhu Z, Ding J, Shankowsky HA, Tredget EE (2013). The molecular mechanism of hypertrophic scar. J. Cell. Commun. Signal., 7 (4), 239-252.
Review
For citations:
Kobets M.V., Vasilyeva L.S. DEPENDENCE OF OUTCOMES OF HYPERTROPHIC SCARS LASER TREATMENT ON THE INITIAL REACTIVITY. Acta Biomedica Scientifica. 2016;1(6):60-65. (In Russ.) https://doi.org/10.12737/23736
Views:
587
.png)
Email this article 
